Eglozel® Tablets
Empagliflozin
Oral antidiabetic agent, Sodium-Glucose Co-Transporter 2 (SGLT2) inhibitor · 10 mg, 25 mg
Manufactured by Petra Pharma – Jordan
1. Product Overview
Eglozel® contains Empagliflozin, a highly effective SGLT2 inhibitor used to improve glycemic control in adults with type 2 diabetes mellitus. It lowers blood glucose by promoting urinary glucose excretion and provides additional cardiovascular and renal benefits.
Available Strengths
10 mg
25 mg